Eupraxia Pharmaceuticals Inc. (EPRX.TO) Income Statement 2017 - 2024

Eupraxia Pharmaceuticals Inc.

Toronto Stock Exchange:EPRX.TO

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

Location

Canada

Market Cap

USD 194.02 M

Share Price

USD 5.24

Avg Daily Volume

36,993

Change (1 day)

-2.89%

Change (1 year)

112.13%

Change (YTD)

67.34%

Eupraxia Pharmaceuticals Inc. Income Statement 2017 - 2024

This table shows the Income Statement for Eupraxia Pharmaceuticals Inc. going from 2017 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.